SH3YL1-TLR5 complex-mediated vicious cycle contributes to FSGS pathogenesis
Abstract
The mechanisms underlying focal segmental glomerulosclerosis (FSGS), particularly podocyte damage, remain unclear. We found that patients with FSGS have significantly elevated serum and urine levels of SH3YL1, especially in more severe cases. Adriamycin stimulates SH3YL1 secretion, which induces proinflammatory cytokines and enhances podocyte injury. The receptor for secreted SH3YL1 is identified as Toll-like receptor 5 (TLR5), with the ectodomain specifically binding SH3YL1 at an affinity of 1.49 × 10⁻⁸ M. In murine FSGS model, knockout of TLR5 or SH3YL1 alleviated renal inflammation, podocyte damage, sclerosis, and tubular injury. The proposed mechanism involves a vicious cycle where renal injury induces SH3YL1 secretion, promoting podocyte death and local inflammation, which further amplifies SH3YL1 secretion. We developed a therapeutic antibody that neutralizes secreted SH3YL1, effectively reducing podocyte death and sclerosis. These findings suggest that the SH3YL1-TLR5 axis drives podocyte damage in FSGS and that the antibody could serve as a promising therapeutic intervention.
Related
- Dipeptidyl peptidase IV contributes to the pathogenesis of Cryptococcus neoformans
- Phase Separation Contributes to Pathogenicity for Nonsense Mediated Decay-Escaping Variant Alleles
- Cooperation between Adh and OR5M11 contributes to the lung pathogenicity of Actinobacillus pleuropneumoniae by facilitating the NLRP3-mediated inflammatory response
- Orai1 Contributes to Platelet-Activating Factor (PAF)-Induced Contraction in Association with Voltage-Dependent Ca²⁺ Channel-Mediated Mechanisms in Guinea Pig Urinary Bladder Smooth Muscle
- Feedforward Inhibition Mediated by Preoptic Area Parvalbumin Neurons Contributes to Orexin-Induced Active Arousal from Anesthesia
BibTeX
@article{lee2026sh3yl1tlr5,
title = {{SH3YL1-TLR5 complex-mediated vicious cycle contributes to FSGS pathogenesis}},
author = {Hye Eun Lee and Jung Yeon Ghee and Eun Jung An and Jung-Yeon Yoo and Soo Hee Lee and Soo-Jin Song and Mi Jin Jee and Ki-Hwan Han and Kyoung-Seok Ryu and In Hye Lee and Seung Hee Yang and Dae Ryong Cha and Yun Soo Bae},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117910},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03293-1},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - SH3YL1-TLR5 complex-mediated vicious cycle contributes to FSGS pathogenesis
AU - Hye Eun Lee
AU - Jung Yeon Ghee
AU - Eun Jung An
AU - Jung-Yeon Yoo
AU - Soo Hee Lee
AU - Soo-Jin Song
AU - Mi Jin Jee
AU - Ki-Hwan Han
AU - Kyoung-Seok Ryu
AU - In Hye Lee
AU - Seung Hee Yang
AU - Dae Ryong Cha
AU - Yun Soo Bae
PY - 2026
DA - 2026/10/22
JO - iScience
DO - 10.1016/j.isci.2026.117910
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03293-1
AB - The mechanisms underlying focal segmental glomerulosclerosis (FSGS), particularly podocyte damage, remain unclear. We found that patients with FSGS have significantly elevated serum and urine levels of SH3YL1, especially in more severe cases. Adriamycin stimulates SH3YL1 secretion, which induces proinflammatory cytokines and enhances podocyte injury. The receptor for secreted SH3YL1 is identified as Toll-like receptor 5 (TLR5), with the ectodomain specifically binding SH3YL1 at an affinity of 1.49 × 10⁻⁸ M. In murine FSGS model, knockout of TLR5 or SH3YL1 alleviated renal inflammation, podocyte damage, sclerosis, and tubular injury. The proposed mechanism involves a vicious cycle where renal injury induces SH3YL1 secretion, promoting podocyte death and local inflammation, which further amplifies SH3YL1 secretion. We developed a therapeutic antibody that neutralizes secreted SH3YL1, effectively reducing podocyte death and sclerosis. These findings suggest that the SH3YL1-TLR5 axis drives podocyte damage in FSGS and that the antibody could serve as a promising therapeutic intervention.
SN - 2589-0042
ER -